GREGORY SKETAS M.D. NPI 1710340088

NPI Information

  • NPI: 1710340088
  • Provider Name: GREGORY SKETAS, M.D.
  • Classification: Family Medicine - 207Q00000X
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 4517 PARK AVE
    HOT SPRINGS, AR
    ZIP 71901
  • Phone: (501) 623-7900

Map and Directions

Get Directions

NPI Details

Gregory Sketas, M.D. is a family medicine in Hot Springs, AR with 9 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. Gregory Sketas, M.D. NPI is 1710340088. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF ARKANSAS COLLEGE OF MEDICINE
Graduation Year:2016

The provider's business location address is:

4517 PARK AVE
HOT SPRINGS, AR
ZIP 71901
Phone: (501) 623-7900
Fax: (501) 623-7337

The NPI 1710340088 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Follow-up nursing facility visit per day, typically 25 minutes (HCPCS:99309)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Follow-up nursing facility visit per day, typically 25 minutes (HCPCS:99309)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Critical care, first 30-74 minutes (HCPCS:99291)
  • Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Hospital discharge day management, more than 30 minutes (HCPCS:99239)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Automated urinalysis test (HCPCS:81003)
  • Hemoglobin a1c level (HCPCS:83036)
  • Initial nursing facility visit per day, typically 35 minutes (HCPCS:99305)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • X-ray of chest, 2 views (HCPCS:71046)
  • Initial nursing facility visit per day, typically 35 minutes (HCPCS:99305)
  • Advance care planning, first 30 minutes (HCPCS:99497)
  • Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
  • Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
  • Annual depression screening, 15 minutes (HCPCS:G0444)
  • Urine microalbumin (protein) level (HCPCS:82043)
  • Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Nursing facility discharge management, more than 30 minutes (HCPCS:99316)
  • Annual alcohol misuse screening, 15 minutes (HCPCS:G0442)
  • Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
  • Initial hospital observation care per day, typically 70 minutes (HCPCS:99220)
  • Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
  • Administration of pneumococcal vaccine (HCPCS:G0009)
  • Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
  • Vitamin d-3 level (HCPCS:82306)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Hospital discharge day management, 30 minutes or less (HCPCS:99238)
  • New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
  • Mri scan of lower spinal canal without contrast (HCPCS:72148)
  • Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
  • Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
  • X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
  • Hepatitis c antibody screening, for individual at high risk and other covered indication(s) (HCPCS:G0472)
  • Follow-up nursing facility visit per day, typically 35 minutes (HCPCS:99310)
  • Initial nursing facility visit per day, typically 45 minutes (HCPCS:99306)
  • Nursing facility discharge management, more than 30 minutes (HCPCS:99316)
  • Mri scan of brain without contrast (HCPCS:70551)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
  • Administration of vaccine (HCPCS:90471)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)

The enumeration date for this NPI number is 4/3/2016 and was last updated on 7/25/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207Q00000XFamily MedicineE-11871ARKANSASYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1E-11871OTHERARKANSASMEDICAL LICENSE

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.